Fundrise’s Innovation Fund, known as VCX, debuted on the NYSE on March 19, 2026, with a net asset value (NAV) of $18.97 per share. Following its listing, retail investors propelled the share price to over $400, significantly above its NAV. As a shareholder, I have observed the volatility surrounding this investment as my shares are locked until September 14, 2026.
The focus of this discussion is to estimate VCX’s NAV by analyzing the adjustments each holding has undergone since listing. To accurately estimate NAV, three steps must be taken. Initially, one must calculate the dilution-adjusted markup for holdings like Anthropic and OpenAI, which have seen substantial valuation increases following new funding rounds.
The second step includes multiplying each company’s growth multiple by its portfolio weight. For instance, Anthropic’s stake in VCX contributed significantly to the fund’s overall growth, emphasizing both promise and risk. As I calculated, VCX could see an approximate NAV of $31 per share by the end of this lockup period.
Future projections suggest that VCX’s NAV could increase to $40-$49 by the end of 2027, assuming continued market optimism surrounding its key holdings. An IPO for Anthropic may further enhance investor interest, thereby influencing VCX’s market price positively post-lockup.
However, skepticism remains due to the nature of closed-end funds like VCX, where retail prices can diverge greatly from NAV. The upcoming IPOs of its main holdings could marketably impact VCX’s desirability, as investors weigh the benefits of purchasing equity in these companies directly against holding VCX shares.
Why this story matters:
- The volatility of VCX shares exemplifies the speculative nature of emerging tech investments.
Key takeaway:
- Future NAV growth is contingent upon successful IPOs and market sentiment, with existing concentrated holdings representing both high potential and significant risk.
Opposing viewpoint:
- Critically, the rapid ascent of the VCX share price reveals the dangers of retail investor speculation detached from fundamental valuations.